Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–20091
Shu-Hua Wang

, Yosef Khan, Lisa Hines, José R. Mediavilla, Liangfen Zhang, Liang Chen, Armando Hoet, Tammy Bannerman, Preeti Pancholi, D. Ashley Robinson, Barry N. Kreiswirth, Kurt B. Stevenson, and for the Prevention Epicenter Program of the Centers for Disease Control and Prevention
Author affiliations: The Ohio State University Wexner Medical Center, Columbus, Ohio, USA (S.H. Wang, Y. Khan, L. Hines, A. Hoet, P. Pancholi, K.B. Stevenson); University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA (J.R. Mediavilla, L. Chen, B.N. Kreiswirth); University of Mississippi Medical Center, Jackson, Mississippi, USA (L. Zhang, D.A. Robinson); and The Ohio Department of Health Laboratories, Reynoldsburg, Ohio, USA (T. Bannerman)
Main Article
Figure 1

Figure 1. . . Methicillin-resistant Staphylococcus aureus sequence type 239-III isolates, Ohio, USA, 2007–2009, based on A) repetitive element PCR (rep-PCR) and B) pulsed-field gel electrophoresis. Virtual gel results are shown for 8 DiversiLab System (bioMérieux, Durham, NC, USA) rep-PCR patterns. Pattern numbers assigned are unique to the Ohio State University Wexner Medical Center.
Main Article
Page created: September 19, 2012
Page updated: September 19, 2012
Page reviewed: September 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.